Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of GoodwillAmortization of GoodwillAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDivestmentsExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avanos Medical (AVNS) Acquisitions (2016 - 2026)

Avanos Medical recorded quarterly Acquisitions of $3.4 million in Q1 2026, up 41.67% quarter-over-quarter from $2.4 million in Q1 2025, and up 41.67% year-over-year from $2.4 million in Q1 2025.

Avanos Medical's Acquisitions history runs 8 years deep, the most recent figure standing at $3.4 million for Q1 2026.

  • In Q1 2026, Acquisitions rose 41.67% year-over-year to $3.4 million; the TTM figure through Mar 2026 stood at $52.9 million (up 1.73% YoY), while the FY2025 annual figure was $28.0 million, changed N/A from the prior year.
  • Acquisitions came in at $3.4 million for Q1 2026 at Avanos Medical, up from $2.4 million in the prior quarter.
  • In the past five years, Acquisitions ranged from a high of $116.7 million in Q1 2022 to a low of -$600000.0 in Q3 2022.
  • A 4-year average of $24.5 million and a median of $2.5 million in 2023 frame the typical range for Acquisitions.
  • Across the five-year window, Acquisitions jumped 7600.0% in 2023 and soared 41.67% in 2026, its largest moves.
  • Avanos Medical's Acquisitions stood at -$600000.0 in 2022, then surged by 450.0% to $2.1 million in 2023, then grew by 14.29% to $2.4 million in 2025, then jumped by 41.67% to $3.4 million in 2026.
  • According to Business Quant data, Acquisitions over the past three periods registered $3.4 million, $2.4 million, and $2.1 million for Q1 2026, Q1 2025, and Q4 2023 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Acquisitions (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 22.00 Mn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 523.00 Mn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -268.10 Mn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 2.30 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -
10 Avanos Medical 1.17 Bn 1.10 Bn 94.20 Mn 3.40 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 3.40 Mn
Mar 31, 2025 2.40 Mn
Dec 31, 2023 2.10 Mn
Sep 30, 2023 45.00 Mn
Jun 30, 2023 2.50 Mn
Sep 30, 2022 -600,000.00
Mar 31, 2022 116.70 Mn
Dec 31, 2020 -4.00 Mn
Sep 30, 2020 4.00 Mn
Sep 30, 2019 50.50 Mn
Dec 31, 2018 100,000.00
Sep 30, 2016 -100,000.00